atNorth Publishes 2024 Sustainability Report
The report showcases atNorth’s advancements in sustainability, energy efficiency and community engagement while outlining its vision for the future of data... Read more.
ZEERO GROUP Joins IATA Strategic Partnerships Program to Further Drive Sustainability in The Travel Industry
LONDON, April 2, 2025 /PRNewswire/ — ZEERO GROUP (ZEERO), a pioneering travel industry collaboration and joint venture dedicated to sustainability, today announced... Read more.
The Linux Foundation Announces General Availability of Valkey 8.1
Valkey 8.1 Release Provides Enhanced Performance and Observability Improvements LONDON, April 2, 2025 /PRNewswire/ — KubeCon + CloudNativeCon Europe — Today,... Read more.
IndySoft Acquires Longtime UK Partner IndySoft Europe LTD
Strategic acquisition strengthens IndySoft’s global footprint and customer support across Europe CHARLESTON, S.C., April 2, 2025 /PRNewswire/ — IndySoft... Read more.
Cloud Native Computing Foundation Member HAProxy Technologies Upgrades to Gold Membership
Strengthening its cloud native commitment with 25 years of open source innovation in application delivery and security LONDON, April 2, 2025 /PRNewswire/ —... Read more.
Data4Life releases Data2Evidence as open source: a new chapter for global health research
POTSDAM, Germany, April 2, 2025 /PRNewswire/ — Data4Life, the nonprofit digital health organization, today announced the open-source release of its research... Read more.
Ericsson Upgrades to Gold Membership in the Cloud Native Computing Foundation to Drive Cloud Native Transformation in Telecom
Ericsson expands cloud native innovation in telecom, leveraging CNCF projects to advance 5G and 6G LONDON, April 2, 2025 /PRNewswire/ — KubeCon + CloudNativeCon... Read more.
Senhwa Biosciences Announces Positive Clinical Data from Phase 1/Expansion Trial of Silmitasertib (CX-4945) in the Treatment of Basal Cell Carcinoma
Basal Cell Carcinoma CSR Highlights CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients... Read more.
Invitation: Presentation of Sandvik’s report of the first quarter 2025
STOCKHOLM, April 2, 2025 /PRNewswire/ — Sandvik will publish its first quarter results on Wednesday, April 16, 2025, at approximately 11:30 AM CEST. A combined... Read more.
Arctic Therapeutics research suggests preventative strategy against HCCAA
N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid angiopathy (CAA) – is an... Read more.